These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6317738)

  • 41. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
    Graham DY; Lew GM; Klein PD; Evans DG; Evans DJ; Saeed ZA; Malaty HM
    Ann Intern Med; 1992 May; 116(9):705-8. PubMed ID: 1558340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of ranitidine and cimetidine in the treatment of chronic gastric ulcer. A double-blind trial.
    Kellow JE; Barr GD; Cowen AE; Ward M; Wood L; Piper DW
    Digestion; 1983; 27(2):105-10. PubMed ID: 6313458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer.
    de Bruijne JW; Snel P; Lamers CB
    Digestion; 1989; 44 Suppl 1():25-30. PubMed ID: 2691308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ranitidine: prophylaxis of duodenal ulcer recurrence.
    Lee FI; Fielding JD; Holmes GK; Hine KR; Gibson JA; Lochee-Bayne E; Mackay C; Mitchell KG; Pickard WR; Orchard RT
    Hepatogastroenterology; 1984 Apr; 31(2):85-7. PubMed ID: 6327479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Duodenal and gastric ulcer healing rates: a review.
    Legerton CW
    Am J Med; 1984 Nov; 77(5B):2-7. PubMed ID: 6095656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
    Yeomans ND
    Am J Med; 1998 Mar; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Ranitidine and cimetidine in long-term (2 years) maintenance therapy of chronic gastric ulcer].
    Varas MJ
    Rev Esp Enferm Apar Dig; 1989 Feb; 75(2):153-6. PubMed ID: 2652217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term treatment of duodenal ulcer.
    Wormsley KG
    S Afr Med J; 1984 Jun; 65(25):1001-4. PubMed ID: 6328683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
    Gut; 1990 Jun; 31(6):653-6. PubMed ID: 2199347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of treatment compliance and overnight gastric secretion on outcome of maintenance therapy of duodenal ulcer with ranitidine.
    Boyd EJ; Wilson JA; Wormsley KG
    Scand J Gastroenterol; 1983 Mar; 18(2):193-200. PubMed ID: 6324330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ranitidine in the maintenance therapy of gastro-duodenal ulcer disease: Polish open multicentre study.
    Gibiński K; Nowak A; Gabryelewicz A; Szałaj W; Hasik J; Klincewicz H; Butruk E; Kosecki P; Pokora J; Radwan P
    Hepatogastroenterology; 1984 Aug; 31(4):180-2. PubMed ID: 6090287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [H2 antagonists and surgery of peptic ulcer].
    de Miguel Gómez J; Gómez Cortijo T; de Miguel del Campo J
    Rev Esp Enferm Apar Dig; 1985 Dec; 68(6):545-7. PubMed ID: 4095357
    [No Abstract]   [Full Text] [Related]  

  • 54. Ranitidine or cimetidine for ulcer healing?
    Langman MJ
    Aliment Pharmacol Ther; 1987 Oct; 1(5):367-8. PubMed ID: 2979680
    [No Abstract]   [Full Text] [Related]  

  • 55. Interim analysis of a comparative trial of ranitidine and cimetidine in the prevention of duodenal ulcer.
    Gough KR
    Am J Med; 1984 Nov; 77(5B):39-42. PubMed ID: 6095660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs].
    Stock KP; Bach GL
    Z Rheumatol; 1988; 47(3):177-81. PubMed ID: 3213266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?
    Yeomans ND; Svedberg LE; Naesdal J
    Int J Clin Pract; 2006 Nov; 60(11):1401-7. PubMed ID: 17073837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapy with H2 receptor antagonists in childhood. Use of ranitidine in duodenal and gastric ulcer and reflux esophagitis].
    Bender SW
    Fortschr Med; 1992 Nov; 110(33):629-32. PubMed ID: 1478605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
    Campoli-Richards DM; Clissold SP
    Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.